Story
Essex Bio-Technology Declares HK$0.05 Interim Dividend for First Half of 2026

Essex Bio-Technology Ltd. (01061.HK) has announced an interim dividend of HK$0.05 per share for the first six months of 2026. The payment is scheduled to be distributed to eligible shareholders on September 2, 2026, according to a company filing reported by Zhitong Finance APP.
Dividend Details
The declared dividend reflects the company's performance for the reporting period ending in the middle of the fiscal year. This distribution provides a direct return to the company's investors.
Key details of the dividend are as follows:
- Dividend Amount: HK$0.05 per ordinary share
- Period Covered: For the six months ending June 30, 2026
- Payment Date: September 2, 2026
AdContext for Investors
An interim dividend is a distribution paid to shareholders before a company's full-year financial results are finalized, typically following the release of half-year earnings. For investors, this payment from Essex Bio-Technology represents a return of capital based on its first-half performance.
Shareholders on the company's register by the yet-to-be-announced record date will be eligible to receive the dividend. The stock will trade ex-dividend one business day prior to the record date, meaning shares purchased on or after the ex-dividend date will not be entitled to the payment.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.